Ensysce Biosciences
Dave Humphrey has served as the Chief Financial Officer since February 2021. Prior to joining the Company, Mr. Humphrey was most recently Chief Financial Officer of Senomyx, a publicly-held biotechnology company focused on taste science.
Previously, he held finance and accounting leadership positions and consulted at numerous life sciences companies, including Active Biosciences, Aurora Biosciences and Gensia.
Mr. Humphrey holds a Bachelor of Science with Honors in Accountancy from the University of Illinois at Urbana-Champaign and is a Certified Public Accountant (CPA) in California.
This person is not in any offices
Ensysce Biosciences
1 followers
Ensysce Biosciences, Inc. (Ensysce) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.